|
1
|
Arvold ND and Reardon DA: Treatment
options and outcomes for glioblastoma in the elderly patient. Clin
Interv Aging. 9:357–367. 2014.PubMed/NCBI
|
|
2
|
Hanif F, Muzaffar K, Perveen K, Malhi SM
and Simjee ShU: Glioblastoma multiforme: A review of its
epidemiology and pathogenesis through clinical presentation and
treatment. Asian Pac J Cancer Prev. 18:3–9. 2017.PubMed/NCBI
|
|
3
|
Tamimi AF and Juweid M: Epidemiology and
outcome of glioblastoma. Chapter 8. In: Glioblastoma [Internet]. De
Vleeschouwer S (ed). Codon Publications. (Brisbane (AU)). 29251870.
2017.
|
|
4
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Galli R, Binda E, Orfanelli U, Cipelletti
B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi
A: Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
9
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim Y, Joo KM, Jin J and Nam DH: Cancer
stem cells and their mechanism of chemo-radiation resistance. Int J
Stem Cells. 2:109–114. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lathia JD, Mack SC, Mulkearns-Hubert EE,
Valentim CL and Rich JN: Cancer stem cells in glioblastoma. Genes
Dev. 29:1203–1217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song WS, Yang YP, Huang CS, Lu KH, Liu WH,
Wu WW, Lee YY, Lo WL, Lee SD, Chen YW, et al: Sox2, a stemness
gene, regulates tumor-initiating and drug-resistant properties in
CD133-positive glioblastoma stem cells. J Chin Med Assoc.
79:538–545. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Neradil J and Veselska R: Nestin as a
marker of cancer stem cells. Cancer Sci. 106:803–811. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gupta PB, Onder TT, Jiang G, Tao K,
Kuperwasser C, Weinberg RA and Lander ES: Identification of
selective inhibitors of cancer stem cells by high-throughput
screening. Cell. 138:645–659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mitani M, Yamanishi T and Miyazaki Y:
Salinomycin: A new monovalent cation ionophore. Biochem Biophys Res
Commun. 66:1231–1236. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong TT, Zhou HM, Wang LL, Feng B, Lv B
and Zheng MH: Salinomycin selectively targets ‘CD133+’
cell subpopulations and decreases malignant traits in colorectal
cancer lines. Ann Surg Oncol. 18:1797–1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y: Effects of salinomycin on cancer
stem cell in human lung adenocarcinoma A549 cells. Med Chem.
7:106–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim KY, Yu SN, Lee SY, Chun SS, Choi YL,
Park YM, Song CS, Chatterjee B and Ahn SC: Salinomycin-induced
apoptosis of human prostate cancer cells due to accumulated
reactive oxygen species and mitochondrial membrane depolarization.
Biochem Biophys Res Commun. 413:80–86. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fuchs D, Daniel V, Sadeghi M, Opelz G and
Naujokat C: Salinomycin overcomes ABC transporter-mediated
multidrug and apoptosis resistance in human leukemia stem cell-like
KG-1a cells. Biochem Biophys Res Commun. 394:1098–1104. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fuchs D, Heinold A, Opelz G, Daniel V and
Naujokat C: Salinomycin induces apoptosis and overcomes apoptosis
resistance in human cancer cells. Biochem Biophys Res Commun.
390:743–749. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu D, Choi MY, Yu J, Castro JE, Kipps TJ
and Carson DA: Salinomycin inhibits Wnt signaling and selectively
induces apoptosis in chronic lymphocytic leukemia cells. Proc Natl
Acad Sci USA. 108:13253–13257. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Magrath JW and Kim Y: Salinomycin's
potential to eliminate glioblastoma stem cells and treat
glioblastoma multiforme (Review). Int J Oncol. 51:753–759. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen T, Yi L, Li F, Hu R, Hu S, Yin Y, Lan
C, Li Z, Fu C, Cao L, et al: Salinomycin inhibits the tumor growth
of glioma stem cells by selectively suppressing glioma-initiating
cells. Mol Med Rep. 11:2407–2412. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qin LS, Jia PF, Zhang ZQ and Zhang SM:
ROS-p53-cyclophilin-D signaling mediates salinomycin-induced glioma
cell necrosis. J Exp Clin Cancer Res. 34:572015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xipell E, Gonzalez-Huarriz M, Martinez de
Irujo JJ, García-Garzón A, Lang FF, Jiang H, Fueyo J, Gomez-Manzano
C and Alonso MM: Salinomycin induced ROS results in abortive
autophagy and leads to regulated necrosis in glioblastoma.
Oncotarget. 7:30626–30641. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:354re32016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Joo KM, Kim J, Jin J, Kim M, Seol HJ,
Muradov J, Yang H, Choi YL, Park WY, Kong DS, et al:
Patient-specific orthotopic glioblastoma xenograft models
recapitulate the histopathology and biology of human glioblastomas
in situ. Cell Rep. 3:260–273. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Friedman GK, Langford CP, Coleman JM,
Cassady KA, Parker JN, Markert JM and Yancey Gillespie G:
Engineered herpes simplex viruses efficiently infect and kill
CD133+ human glioma xenograft cells that express CD111.
J Neurooncol. 95:199–209. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu Y and Smyth GK: ELDA: Extreme limiting
dilution analysis for comparing depleted and enriched populations
in stem cell and other assays. J Immunol Methods. 347:70–78. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bai X, Kinney WH, Su WL, Bai A, Ovrutsky
AR, Honda JR, Netea MG, Henao-Tamayo M, Ordway DJ, Dinarello CA and
Chan ED: Caspase-3-independent apoptotic pathways contribute to
interleukin-32γ-mediated control of mycobacterium tuberculosis
infection in THP-1 cells. BMC Microbiol. 15:392015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu G, Zou H, Luo T, Long M, Bian J, Liu
X, Gu J, Yuan Y, Song R, Wang Y, et al: Caspase-dependent and
caspase-independent pathways are involved in cadmium-induced
apoptosis in primary rat proximal tubular cell culture. PLoS One.
11:e01668232016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Klose J, Trefz S, Wagner T, Steffen L,
Preißendörfer Charrier A, Radhakrishnan P, Volz C, Schmidt T,
Ulrich A, Dieter SM, et al: Salinomycin: Anti-tumor activity in a
pre-clinical colorectal cancer model. PLoS One. 14:e02119162019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tigli Aydin RS, Kaynak G and
Gumusderelioglu M: Salinomycin encapsulated nanoparticles as a
targeting vehicle for glioblastoma cells. J Biomed Mater Res A.
104:455–464. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kemper K, Sprick MR, de Bree M, Scopelliti
A, Vermeulen L, Hoek M, Zeilstra J, Pals ST, Mehmet H, Stassi G and
Medema JP: The AC133 epitope, but not the CD133 protein, is lost
upon cancer stem cell differentiation. Cancer Res. 70:719–729.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Al Dhaheri Y, Attoub S, Arafat K, Abuqamar
S, Eid A, Al Faresi N and Iratni R: Salinomycin induces apoptosis
and senescence in breast cancer: Upregulation of p21,
downregulation of survivin and histone H3 and H4 hyperacetylation.
Biochim Biophys Acta. 1830:3121–3135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kaplan F and Teksen F: Apoptotic effects
of salinomycin on human ovarian cancer cell line (OVCAR-3). Tumour
Biol. 37:3897–3903. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He YC, Zhou FL, Shen Y, Liao DF and Cao D:
Apoptotic death of cancer stem cells for cancer therapy. Int J Mol
Sci. 15:8335–8351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Parajuli B, Shin SJ, Kwon SH, Cha SD,
Chung R, Park WJ, Lee HG and Cho CH: Salinomycin induces apoptosis
via death receptor-5 up-regulation in cisplatin-resistant ovarian
cancer cells. Anticancer Res. 33:1457–1462. 2013.PubMed/NCBI
|
|
41
|
Calzolari A, Saulle E, De Angelis ML,
Pasquini L, Boe A, Pelacchi F, Ricci-Vitiani L, Baiocchi M and
Testa U: Salinomycin potentiates the cytotoxic effects of TRAIL on
glioblastoma cell lines. PLoS One. 9:e944382014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Norouzi M, Abdali Z, Liu S and Miller DW:
Salinomycin-loaded nanofibers for glioblastoma therapy. Sci Rep.
8:93772018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rollinson J, Taylor FG and Chesney J:
Salinomycin poisoning in horses. Vet Rec. 121:126–128. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Story P and Doube A: A case of human
poisoning by salinomycin, an agricultural antibiotic. N Z Med J.
117:U7992004.PubMed/NCBI
|
|
45
|
van der Linde-Sipman JS, van den Ingh TS,
van nes JJ, Verhagen H, Kersten JG, Beynen AC and Plekkringa R:
Salinomycin-induced polyneuropathy in cats: Morphologic and
epidemiologic data. Vet Pathol. 36:152–156. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Boehmerle W and Endres M: Salinomycin
induces calpain and cytochrome C-mediated neuronal cell death. Cell
Death Dis. 2:e1682011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Borgstrom B, Huang X, Hegardt C, Oredsson
S and Strand D: Structure-activity relationships in salinomycin:
Cytotoxicity and phenotype selectivity of semi-synthetic
derivatives. Chemistry. 23:2077–2083. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xipell E, Aragón T, Martinez-Velez N, Vera
B, Idoate MA, Martínez-Irujo JJ, Garzón AG, Gonzalez-Huarriz M,
Acanda AM, Jones C, et al: Endoplasmic reticulum stress-inducing
drugs sensitize glioma cells to temozolomide through downregulation
of MGMT, MPG, and Rad51. Neuro Oncol. 18:1109–1119. 2016.
View Article : Google Scholar : PubMed/NCBI
|
